Hu Q, Xing JY, Wu P, Huang TT, Yang XD. [Role of the ES-62 protein derived from
Acanthocheilonema viteae in regulation of
immune dysregulation diseases: a review].
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2021;
34:204-211. [PMID:
35537846 DOI:
10.16250/j.32.1374.2021141]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
ES-62 is a phosphorylcholine-containing, 62 kDa glycoprotein derived from the excretory-secretory product of Acanthocheilonema viteae, which is effective for the prevention and treatment of immune dysregulation diseases through triggering activation of immune cells, such as dendritic cells, mononuclear macrophages and regulatory B cells and mediating immune responses. Recently, the role of the ES-62 protein in the management of allergic, autoimmune and metabolic diseases has been paid much attention. This review summarizes the regulatory role of the ES-62 protein in immune dysregulation diseases and the underlying mechanisms, so as to provide insights into future experimental studies.
Collapse